Rick Doblin of MAPS Talks Medical Cannabis Trials and a Possible Legalization Timeline

There may be no one in America who cares more deeply about the end of cannabis prohibition than Dr. Rick Doblin. Since 1986, he has been executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit running FDA-approved clinical trials to study the medical efficacy of Schedule I controlled substances such as cannabis and MDMA.

Due to the remarkable success of their Phase II studies, MAPS recently received FDA approval to conduct large-scale, Phase III clinical trials for MDMA-assisted psychotherapy for treating post-traumatic stress disorder (PTSD). MAPS has also received FDA approval to study the safety and efficacy of medical cannabis in treating symptoms of PTSD. Gaining government approval for these studies is no easy task—the process is expensive and time-consuming, especially for federally illegal substances.

In the US, research on the efficacy of medical marijuana has moved even more

... read more at: https://www.leafly.com/news/health/rick-doblin-on-medical-marijuana-and-legalization

Leave a Reply

Your email address will not be published. Required fields are marked *